Bovie Medical Company Profile (AMEX:BVX)

About Bovie Medical (AMEX:BVX)

Bovie Medical logoBovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Equipment Wholesale
  • Sub-Industry: N/A
  • Symbol: AMEX:BVX
  • CUSIP: N/A
  • Web:
  • Market Cap: $105.85 million
  • Outstanding Shares: 30,859,000
Average Prices:
  • 50 Day Moving Avg: $2.97
  • 200 Day Moving Avg: $2.58
  • 52 Week Range: $1.87 - $5.75
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -85.75
  • P/E Growth: -2.02
Sales & Book Value:
  • Annual Revenue: $37.75 million
  • Price / Sales: 2.80
  • Book Value: $0.76 per share
  • Price / Book: 4.51
  • EBITDA: ($3,600,000.00)
  • Net Margins: -13.35%
  • Return on Equity: -21.74%
  • Return on Assets: -15.98%
  • Average Volume: 156,770 shs.
  • Beta: -0.06
  • Short Ratio: 2.61

Frequently Asked Questions for Bovie Medical (AMEX:BVX)

What is Bovie Medical's stock symbol?

Bovie Medical trades on the AMEX under the ticker symbol "BVX."

How were Bovie Medical's earnings last quarter?

Bovie Medical Co. (AMEX:BVX) released its earnings results on Wednesday, August, 2nd. The company reported ($0.04) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business earned $9.80 million during the quarter, compared to analyst estimates of $8.60 million. Bovie Medical had a negative net margin of 13.35% and a negative return on equity of 21.74%. View Bovie Medical's Earnings History.

When will Bovie Medical make its next earnings announcement?

Bovie Medical is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Bovie Medical.

Where is Bovie Medical's stock going? Where will Bovie Medical's stock price be in 2017?

1 equities research analysts have issued twelve-month target prices for Bovie Medical's stock. Their forecasts range from $6.00 to $6.00. On average, they expect Bovie Medical's share price to reach $6.00 in the next twelve months. View Analyst Ratings for Bovie Medical.

Who are some of Bovie Medical's key competitors?

Who are Bovie Medical's key executives?

Bovie Medical's management team includes the folowing people:

  • Andrew Makrides Esq., Executive Chairman of the Board
  • John Robert Saron, President, Chief Sales and Marketing Officer, Director
  • Robert L. Gershon, Chief Executive Officer, Director
  • Charles Thomas Orsatti, Vice Chairman of the Board
  • Jay D. Ewers, Chief Financial Officer, Treasurer, Secretary
  • Moshe Citronowicz, Senior Vice President
  • John J. McCarthy, Chief Commercialization Officer
  • John C. Andres, Independent Director
  • Scott R. Davidson, Independent Director
  • Michael E. Geraghty, Independent Director

How do I buy Bovie Medical stock?

Shares of Bovie Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bovie Medical's stock price today?

One share of Bovie Medical stock can currently be purchased for approximately $3.43.

MarketBeat Community Rating for Bovie Medical (AMEX BVX)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bovie Medical (AMEX:BVX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.00
Consensus Price Target History for Bovie Medical (AMEX:BVX)
Price Target History for Bovie Medical (AMEX:BVX)
Analysts' Ratings History for Bovie Medical (AMEX:BVX)
DateFirmActionRatingPrice TargetDetails
11/21/2016Piper Jaffray CompaniesInitiated CoverageOverweight$6.00View Rating Details
8/3/2016JMP SecuritiesReiterated RatingOutperform$5.00View Rating Details
(Data available from 10/17/2015 forward)


Earnings History for Bovie Medical (AMEX:BVX)
Earnings by Quarter for Bovie Medical (AMEX:BVX)
Earnings History by Quarter for Bovie Medical (AMEX BVX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017($0.02)N/AView Earnings Details
8/2/2017Q2 2017($0.03)($0.04)$8.60 million$9.80 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.05)($0.06)$8.39 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.01)($0.04)$9.90 million$9.49 millionViewListenView Earnings Details
10/26/2016Q216($0.03)($0.01)$9.25 million$10.10 millionViewListenView Earnings Details
8/1/2016Q2 2016($0.06)($0.02)$8.55 million$9.30 millionViewN/AView Earnings Details
5/11/2016Q116($0.05)($0.07)$7.17 million$7.80 millionViewListenView Earnings Details
3/17/2016Q415($0.06)($0.05)$8.69 million$8.30 millionViewListenView Earnings Details
11/4/2015Q315($0.06)($0.07)$7.40 million$7.80 millionViewN/AView Earnings Details
8/6/2015Q215($0.09)($0.06)$7.27 million$7.27 millionViewN/AView Earnings Details
5/8/2015Q1 2015($0.13)($0.14)$6.92 million$6.13 millionViewN/AView Earnings Details
2/27/2015Q4($0.12)$7.47 millionViewN/AView Earnings Details
8/5/2014Q2 2014($0.02)($0.03)$6.95 millionViewN/AView Earnings Details
5/15/2014Q1 2014($0.05)($0.01)$6.48 millionViewN/AView Earnings Details
11/14/2013Q3($0.02)$6.70 million$5.80 millionViewN/AView Earnings Details
8/14/2013Q2 2013($0.06)$7.44 million$6.04 millionViewN/AView Earnings Details
5/15/2013Q1 2013($0.02)$6.73 million$5.70 millionViewN/AView Earnings Details
4/1/2013Q4 2012($0.05)$6.10 million$6.83 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bovie Medical (AMEX:BVX)
Current Year EPS Consensus Estimate: $-0.11 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS


Dividend History for Bovie Medical (AMEX:BVX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Bovie Medical (AMEX:BVX)
Insider Trades by Quarter for Bovie Medical (AMEX:BVX)
Institutional Ownership by Quarter for Bovie Medical (AMEX:BVX)
Insider Trades by Quarter for Bovie Medical (AMEX:BVX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/17/2016John J Mccarthy IIIInsiderBuy90,750$3.30$299,475.00View SEC Filing  
12/22/2015John J Mccarthy IIIInsiderBuy25,000$1.98$49,500.00View SEC Filing  
12/21/2015Moshe CitronowiczVPBuy20,000$1.84$36,800.00View SEC Filing  
12/21/2015Robert GershonCEOBuy10,000$1.82$18,200.00View SEC Filing  
8/14/2015Robert GershonCEOBuy20,000$2.39$47,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Bovie Medical (AMEX:BVX)
Latest Headlines for Bovie Medical (AMEX:BVX)
DateHeadline logoBovie Medical Co. (BVX) Set to Announce Earnings on Tuesday - October 17 at 5:20 AM logoBovie Medical Co. (BVX) Upgraded to "Hold" at Zacks Investment Research - October 16 at 8:44 PM logoETFs with exposure to Bovie Medical Corp. : September 22, 2017 - September 22 at 3:49 PM logoBovie Medical Corp. :BVX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017 - September 21 at 4:39 PM logoBovie Medical Co. (AMEX:BVX) Issues Quarterly Earnings Results - August 3 at 3:38 PM logoBovie reports 2Q loss - August 2 at 10:34 PM logoBovie Medical Co. (AMEX:BVX) to Release Quarterly Earnings on Wednesday - July 26 at 7:32 AM logoETFs with exposure to Bovie Medical Corp. : July 10, 2017 - July 10 at 4:47 PM logoBovie Medical Corporation to Release Second Quarter 2017 Financial Results on August 2, 2017 - July 10 at 4:47 PM logoBovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece - Business Wire (press release) - March 29 at 12:33 PM logoBovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece - March 27 at 12:45 PM logoBOVIE MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events - December 22 at 9:13 PM logoCVS Health Introduces Transform Diabetes Care Program - December 16 at 4:24 PM logoBOVIE MEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia - November 14 at 6:53 AM logoBovie Medical Corporation (BVX) Subsides on Stock Offerings - November 12 at 11:11 AM logoBovie Medical Prices Public Offerings Of Common Stock - November 10 at 12:27 PM logoBovie Medical Corporation's (BVX) CEO Rob Gershon on Q3 2016 Results - Earnings Call Transcript - October 27 at 8:32 AM logoBovie Medical Receives FDA 510(k) Clearance For Its 'PlazXact™' Ablator - August 18 at 9:28 PM logoJMP Securities Reviews Bovie Medical's Q2 Results - August 2 at 9:40 PM logoBovie Medical's (BVX) CEO Robert Gershon on Q2 2016 Results - Earnings Call Transcript - August 2 at 8:48 AM logoBOVIE MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi - March 18 at 8:31 AM logoBOVIE MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits - October 19 at 4:11 PM


Social activity is not available for this stock.


Bovie Medical (BVX) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.